K2 THERAPEUTICS, INC.
New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: Jun 17, 2014
Total Offering
$42,743,763
Amount Sold
$30,332,199
Investors
8
First Sale
May 30, 2014
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2012
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jeffrey Stein | Related Person |
| Kevin Forrest | Related Person |
| Kevin Judice | Related Person |
| Dan Burgess | Related Person |
| Scott Rocklage | Related Person |
| Ted Schroeder | Related Person |
| Steve Elms | Related Person |
| Patrick Heron | Related Person |
| Nina Kjellson | Related Person |
Company
SEC Filing
0001610618-14-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free